Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled Mar. 6, 2020

Somerset v. Partners Pharmacy, LLC

Judge
Colleen McMahon
Docket
1:20-cv-01241
Court
U.S. District Court · Southern District of New York
Pages
5
Civil ProcedurePro Se
In one sentence

In Somerset v. Partners Pharmacy, Judge McMahon dismissed the pro se complaint as barred by an earlier judgment and denied fee-free appeal status.

Who this affects

Jerry Somerset’s complaint was dismissed, and he was denied permission to proceed without prepaying fees for an appeal. Partners Pharmacy, LLC was the defendant affected by the dismissal. The warning could affect Somerset’s ability to file future actions without prior permission if the stated conduct continues.

What happened

In Jerry Somerset v. Partners Pharmacy, LLC, Jerry Somerset alleged that Partners Pharmacy used his vehicle to transport opioid drugs and caused emotional distress, lost income, and the unlawful taking of his vehicle. He sought $75 million and referred to disability-related equal treatment.

The court said Somerset had previously litigated the same underlying transactions in state and federal court. It also noted that he filed an identical complaint in another federal court on the same day. The court concluded that the claim-preclusion rule barred this action.

Judge Colleen McMahon dismissed the complaint, declined to allow an amended complaint because amendment would be futile, and denied fee-free status for an appeal. She warned that continued duplicative or meritless filings could lead to a future order requiring Somerset to explain why he should not be barred from filing new actions without prior permission.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Somerset v. Partners Pharmacy, LLC · No. 1:20-cv-01241
Judge
Colleen McMahon
Date
Mar. 6, 2020

Background

Jerry Somerset, representing himself and proceeding without paying filing fees, sued Partners Pharmacy, LLC under asserted federal-question and diversity jurisdiction. Somerset alleged that Partners Pharmacy intentionally used his vehicle to transport opioid drugs in violation of federal and state regulations. He also alleged emotional distress, lost income, and the unlawful taking of his vehicle. He sought $75 million for “loss of human rights” and disability-related equal treatment.

The court noted that Somerset resides in New Jersey and that Partners Pharmacy is located in New Jersey. It also found that Somerset mailed an identical complaint to a federal court in Pennsylvania on the same day. The court had previously dismissed a separate filing in the Southern District of New York as duplicative of this case.

Court’s Reasoning

Because Somerset was proceeding without prepaying fees, the court was required to dismiss the complaint if it was frivolous, failed to state a claim, sought relief from an immune defendant, or fell outside the court’s subject-matter jurisdiction. The court also explained that self-represented pleadings are read liberally but still must comply with the requirement to provide a short and plain statement showing entitlement to relief.

The court relied on the claim-preclusion doctrine, also called res judicata. That doctrine generally prevents a party from bringing later claims arising from the same underlying facts after a prior final judgment. The court reviewed Somerset’s prior related state and federal litigation and relied on the dismissal order in his earlier federal case in New Jersey, which had held that the same underlying transactions were covered by claim preclusion even though Somerset had added allegations about opioids.

Although claim preclusion is ordinarily raised by the defendant, the court stated that it could apply the doctrine on its own because avoiding repetitive litigation and inconsistent decisions serves the interests of the parties and the courts.

Disposition

The court dismissed Somerset’s complaint on claim-preclusion grounds under 28 U.S.C. § 1915(e)(2)(B)(ii). Judge Colleen McMahon declined to grant leave to amend because the defects could not be cured by amendment. The court also warned that continued duplicative or otherwise meritless litigation could result in an order requiring Somerset to show why he should not be barred from filing new actions without prior permission. Finally, the court certified that an appeal would not be taken in good faith and denied Somerset permission to proceed without prepaying fees for an appeal.

The authoritative version

Read the full 5-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.